Cate Carey is a Senior Clinical Project Coordinator in the Therapeutic and Vaccine Research Programme. Cate is responsible for the coordination and implementation of large scale, multi-centre, international clinical trials. Research interests include treatment, pulmonary function and neurological affects in both HIV and infectious disease.
Senior Clinical Project Coordinator
Ms Cate Carey
RN, BA MAppSc
Publications
Journal articles
Wyman Engen N; Huppler Hullsiek K; Belloso WH; Finley E; Hudson F; Denning E; Carey C; Pearson M; Kagan J, 2020, 'A randomized evaluation of on-site monitoring nested in a multinational randomized trial', Clinical Trials, 17, pp. 3 - 14, http://dx.doi.org/10.1177/1740774519881616
2020
Wright EJ; Grund B; Robertson KR; Cysique L; Brew BJ; Collins GL; Poehlman-Roediger M; Vjecha MJ; Penalva De Oliveira AC; Standridge B; Carey C; Avihingsanon A; Florence E; Lundgren JD; Arenas-Pinto A; Mueller NJ; Winston A; Nsubuga MS; Lal L; Price RW, 2018, 'No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts', AIDS, 32, pp. 985 - 997, http://dx.doi.org/10.1097/QAD.0000000000001778
2018
Lifson AR; Grund B; Gardner EM; Kaplan R; Denning E; Engen N; Carey CL; Chen F; Dao S; Florence E; Sanz J; Emery S, 2017, 'Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection', AIDS, 31, pp. 953 - 963, http://dx.doi.org/10.1097/QAD.0000000000001417
2017
Larson GS; Carey C; Grarup J; Hudson F; Sachi K; Vjecha MJ; Gordin F, 2016, 'Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials', Clinical Trials, 13, pp. 127 - 136, http://dx.doi.org/10.1177/1740774515625974
2016
Hullsiek KH; Kagan JM; Engen N; Grarup J; Hudson F; Denning ET; Carey C; Courtney-Rodgers D; Finley EB; Jansson PO; Pearson MT; Peavy DE; Belloso WH, 2015, 'Investigating the Efficacy of Clinical Trial Monitoring Strategies: Design and Implementation of the Cluster Randomized START Monitoring Substudy', Therapeutic Innovation and Regulatory Science, 49, pp. 225 - 233, http://dx.doi.org/10.1177/2168479014555912
2015
Grarup J; Rappoport C; Engen N; Carey C; Hudson F; Denning E; Sharma S; Florence E; Vjecha M, 2015, 'Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial', HIV Medicine, 16, pp. 14 - 23, http://dx.doi.org/10.1111/hiv.12229
2015
Lundgren J; Babiker A; Gordin F; Emery S; Fätkenheuer G; Molina JM; Wood R; Neaton JD; Agan BK; Alston-Smith B; Arenas-Pinto A; Arribas JR; Baker JV; Baxter J; Belloso WH; Brekke K; Brew B; Brobst SW; Burman W; Carey C; Clark R; Cooper DA; Davey RT; De La Rosa G; Denning ET; Dolan M; Dore G; Duprez D; Emanuel E; Grady C; Grund B; Hirschel B; Hoen B; Hudson F; Johnson MA; Kambili C; Klingman K; Kunisaki KM; Landay A; Ledergerber B; Lehrman SN; Martinez A; Meger S; Misar K; Mitsuyasu RT; Mocroft A; Munroe D; Norton M; Palmer RC; Pett SL; Phillips A; Pillay D; Porter D; Price RW; Proschan M; Rappoport C; Reiss P; Renjifo B; Robertson K; Rockstroh J; Rodriguez G; Rooney JF; Ross MJ; Schechter M; Schwarze S; Seekins D; Sharma S; Snowden W; Telenti A; Tryon J; van Wyk J; Vjecha MJ; Wright E, 2015, 'Why START? Reflections that led to the conduct of this large long-term strategic HIV trial', HIV Medicine, 16, pp. 1 - 9, http://dx.doi.org/10.1111/hiv.12227
2015
Pett SL; Carey C; Lin E; Wentworth D; Lazovski J; Miro J; Gordin F; Angus B; Rodriguez-Barradas M; Rubio R; Tambussi G; Cooper DA; Emery S, 2011, 'Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)', HIV Medicine, 12, pp. 219 - 227, http://dx.doi.org/10.1111/j.1468-1293.2010.00875.x
2011
Tavel JA; Babiker A; Carey C; Fisher M; Fox L; Gey D; Lopardo GD; Lopez JC; Markowitz N; Munroe D; Paton N; Ruxrungtham K; Standridge B; Wentworth D; Wyman N; Aagaard B; Borup L; Grarup J; Jansson PO; Jensen K; Lundgren J; Mollerup D; Reilev S; Braimah N; Darbyshire J; Horton J; King E; Smith N; Van Hooff F; Cooper DA; Courtney-Rodgers D; Emery S; Finley E; Gordin F; Sánchez A; Thomas D; Bebchuk J; Bollenbeck P; Denning E; DuChene AG; Fosdick L; Harrison M; Krum E; Larson G; Neaton JD; Nelson R; Quan K; Quan SFL; Schultz T; Thompson G; Collins S; Haerry DH; Meulbroek M; Peavy D; Rappoport C; Schwarze S; Valdez M; Watson J; Belloso WH; Davey R; Duprez D; Gatell JM; Hoy J; Lifson A; Pederson C; Perez G; Price R; Prineas R; Rhame F; Sampson JH; Worley J; Modlin JF; Beral V; Chaisson RE; Fleming TR; Hill C; Kim KM; Murray BE; Pick B; Seligmann M; Weller I; Luzar MA; Martinez A; Costas V; Eckstrand J; Brown S; Lupo SH; Losso MH; Anderson J; Chuah J; Kelly M; Orth D; Wolff MJ; Rusconi S; Tambussi G; Horban A; Antunes F; Mansinho K; Da Conceicao Vera JAV; Himmich H, 2010, 'Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: The STALWART study', PLoS ONE, 5, http://dx.doi.org/10.1371/journal.pone.0009334
2010
Harris L; Jones M; Carey C, 2009, 'Characteristics of blood-injection-injury fears in people receiving intravenous chemotherapy', Current Psychology, 28, pp. 124 - 132, http://dx.doi.org/10.1007/s12144-009-9048-z
2009
Lifson A; Belloso WH; Carey C; Davey R; Duprez D; El-Sadr W; Gatell J; Gey D; Hoy JF; Krum E; Nelson R; Nixon D; Paton N; Pedersen C; Perez G; Price RA; Prineas R; Rhame F; Sampson J; Worley J, 2008, 'Determination of the underlying cause of death in three multicenter international HIV clinical trials', HIV Clinical Trials, 9, pp. 177 - 185, http://dx.doi.org/10.1310/hct0903-177
2008